Taiji Pharmaceutical

Policy / Regulatory

HMZS Biopharmaceutical Blacklisted After Failing to Monitor Production Process

Fineline Cube Mar 18, 2025

HMZS Biopharmaceutical, a Chinese company that won a bid for its phloroglucinol in the 10th...

Company Drug

Novo Nordisk semaglutide Alzheimer’s biomarkers fail primary endpoint

Company Medical Device

Acotec V-otter Microcatheter Secures NMPA Approval for TACE Procedures

Company Deals

Youjia-Bio Tongee-Medical Nucleic-Acid-Drug Partnership Targets Diabetes

Company Drug

Fosun-Pharma FXS0887 ATR-Inhibitor Gets NMPA Phase 1 Nod